Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (7) , 437-442
- https://doi.org/10.1016/j.autrev.2006.02.004
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humansNature Genetics, 2005
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphomaArthritis & Rheumatism, 2003
- Therapeutic strategies for rheumatoid arthritisNature Reviews Drug Discovery, 2003
- Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsNature, 2002
- The Role of B Lymphocytes as Key Antigen-Presenting Cells in the Development of T Cell-Mediated Autoimmune Type 1 DiabetesPublished by S. Karger AG ,2002
- Organogenic Role of B Lymphocytes in Mucosal ImmunityScience, 1999
- Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphomaRheumatology, 1999
- Affinity maturation without germinal centres in lymphotoxin-α-deficient miceNature, 1996
- How important are t cells in chronic rheumatoid synovitis?Arthritis & Rheumatism, 1990